Chargement en cours...

Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia

Hematopoietic stem cell transplantation (HSCT) is a critical treatment modality for many hematological and non-hematological diseases that is being extended to treat older individuals. However, recent studies show that clonal hematopoiesis of indeterminate potential (CHIP), a common, asymptomatic co...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Stem Cell Reports
Auteurs principaux: Burns, Sarah S., Kapur, Reuben
Format: Artigo
Langue:Inglês
Publié: Elsevier 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7419737/
https://ncbi.nlm.nih.gov/pubmed/32783925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stemcr.2020.07.008
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!